TP53 and ovarian cancer: Li–Fraumeni syndrome is an autosomal dominant syndrome determined by heterozygous germline mutations in the tumor suppressor gene TP53. Less frequent tumors (15%) associated with Li–Fraumeni syndrome include ovarian cancer and occur at an earlier age compared to the onset age of sporadic ovarian cancer [26,27].